Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

AGM Statement

19 Jul 2012 07:00

RNS Number : 9817H
Byotrol PLC
19 July 2012
 



19 July 2012

 

Byotrol plc

AGM Statement

 

At the Annual General Meeting of Byotrol plc ('Byotrol' or 'the Company'), the leading AIM listed anti-microbial hygiene company, to be held today at 60 New Broad St, London, EC2M 1JJ at 2.30pm, the Chairman, Ralph Kugler, will make the following statement:

 

"The team at Byotrol continues to make encouraging progress and has maintained the momentum seen in the second half of last year into the current financial year. 

 

Negotiations with our Fortune 150 consumer market partner remain on track to deliver a full commercial agreement in line with the timescales set out in our update to the market on 12 April 2012.

 

The product launches in conjunction with Rentokil Initial Plc have been successful and the resulting order flow is encouraging.

 

The balance sheet remains strong. The Company reported holding £1.62m in cash at 31 March 2012 when it announced its preliminary results in June. This figure was ahead of expectations, reflects our rigorous cost control and demonstrates a robustness in the organisation. This positions the Company well to achieve its objective of positive cash generation at the earliest opportunity.

 

The Board of Byotrol remains optimistic about the prospects for the business and looks forward to updating the market further in due course."

 

 

Enquiries:

 

Byotrol plc

01925 742000

Ralph Kugler, Chairman

 

Gary Millar, Chief Executive

 

Duncan Grosvenor, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Nominated Adviser and broker

 

Geoff Nash/Christopher Raggett

 

 

 

Winningtons

020 3176 4722

Tom Cooper/Paul Vann

0797 122 1972

 

tom.cooper@winningtons.co.uk

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading anti-microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, microbacteria and algae.

 

The Byotrol product can be used as a stand alone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services. Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFFSDLITLIF
Date   Source Headline
23rd Aug 201811:30 amRNSFinal Results
1st Aug 20187:00 amRNSNotice of Results
17th May 20187:00 amRNSFirst US Retail Trial with Target
10th May 20184:32 pmRNSHolding(s) in Company
10th May 20187:00 amRNSState approval in US
23rd Apr 20183:07 pmRNSHolding(s) in Company
11th Apr 20187:00 amRNSTrading Statement
26th Feb 20183:10 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSDirector Dealing
14th Dec 20177:01 amRNSKey US Hire & Grant of Options
14th Dec 20177:00 amRNSInterim Results
7th Dec 20177:00 amRNSNotice of Results
10th Nov 20177:00 amRNSGrant of Options & Director/PDMR Shareholdings
28th Sep 201711:49 amRNSResult of AGM
6th Sep 201712:48 pmRNSHolding(s) in Company
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
6th Sep 201711:31 amRNSHolding(s) in Company
5th Sep 20174:37 pmRNSHolding(s) in Company
5th Sep 20174:36 pmRNSHolding(s) in Company
5th Sep 20174:35 pmRNSHolding(s) in Company
4th Sep 201711:57 amRNSResult of General Meeting
31st Aug 20177:00 amRNSResult of Open Offer
30th Aug 20179:24 amRNSPosting of Annual Report and Notice of AGM
29th Aug 20171:19 pmRNSConversion of Loan Notes and Issue of Equity
17th Aug 20172:31 pmRNSHolding(s) in Company
8th Aug 20174:47 pmRNSPlacing & Open Offer Timetable
7th Aug 20179:44 amRNSHolding(s) in Company
3rd Aug 201712:00 pmRNSResult of Proposed Fundraising
3rd Aug 20177:01 amRNSProposed Fundraising
3rd Aug 20177:00 amRNSFinal Results
13th Jun 20177:00 amRNSEPA Approval
13th Mar 20177:00 amRNSAcquisition
6th Feb 20177:00 amRNSDirector Dealing
1st Feb 20177:00 amRNSBoard changes and issue of options
13th Dec 20167:00 amRNSInterim Results
7th Dec 201612:29 pmRNSNotice of Interim Results
14th Oct 20167:00 amRNSGrant of Options and Director Shareholdings
12th Oct 20167:00 amRNSTransfer of Convertible Loan Notes
30th Sep 20163:16 pmRNSResult of Noteholders Meeting
22nd Sep 20164:51 pmRNSResult of AGM
9th Sep 20167:00 amRNSProposed Revision to Loan Notes
18th Aug 20167:00 amRNSFinal Results
8th Jul 20167:00 amRNSTrading Update and Notice of AGM
25th Feb 20167:00 amRNSTrading Statement
19th Feb 20163:34 pmRNSDirector/PDMR Shareholding
3rd Dec 20158:00 amRNSGrant of Options
3rd Dec 20157:00 amRNSInterim Results
9th Sep 201512:06 pmRNSHolding(s) in Company
8th Sep 20154:05 pmRNSResult of AGM and Completion of Placing
24th Aug 20151:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.